.png)
Our team specializes in identifying non-FDA-approved medication utilization to achieve organizational compliance, and recouping misspent dollars, when applicable.
Learn MoreThrough a decade of pharmaceutical manufacturer and medication research, we utilize a self-created list of more than 7,000 National Drug Codes (NDC) without FDA approval that are found within national drug databases used by PBMs.
Pharmacy utilization that matches NDCs on this list will confirm the total client amount paid for these medications. The remuneration will be provided in the form of a direct client reimbursement or via credits on future invoices, and Vickers Consulting will serve as the internal compliance department to facilitate the refund process.
"As a health plan, our members expect service that is fair, honest and legal. The Vickers Consulting team was able to identify the number of FDA unapproved drugs filled by our plan and the potential liability to our organization. Vickers Consulting has become a vital risk reduction strategy for Excel Health Plans. We strongly encourage your organization to participate in their simple, seamless process."
"At ELK Benefit Strategies, we understand the critical significance of pharmacy benefit compliance, risk management, and cost containment for plan sponsors. As part of our extensive suite of pharmacy consulting services, we have established a strategic partnership with Vickers Consulting. This collaboration empowers us to provide retrospective and ongoing pharmacy compliance assessments to our existing clients and potential partners. These assessments play a crucial role in identifying non-FDA-approved medication utilization, ensuring comprehensive compliance and risk mitigation strategies for our clients' long-term success."
"At RxClarity Group, we leave no stone left unturned in our quest to dramatically reduce pharmacy spend and improve lives, one member at a time. Our partnership with Vickers Consulting plays a crucial role in identifying excessive spending and safety issues related to non-FDA approved medications distributed by PBMs. By leveraging this collaboration, we strengthen our platform, refine our processes, and enhance precision in reviewing pharmacy costs while optimizing clinical care."
